Home › Calculator › CLRB Dividend Calculator 2026
CLRB Dividend DRIP Calculator 2026
78.74% YieldHealthcareCellectar Biosciences, Inc. · NASDAQ
Price: $2.54 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CLRB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CLRB snowball 📈
$10,000 in CLRB → $3.33M in 10 years · $122,183.98/month
About Cellectar Biosciences, Inc. (CLRB) — Dividend Analysis 2026
Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials targeting a range of pediatric cancers, r/r head and neck cancers, and R/R MM. Furthermore, Cellectar is advancing CLR 1900, another PDC-based chemotherapeutic program, which is in preclinical stages with the aim of treating solid tumors. The firm also participates in collaborative PDC development initiatives with partners such as Avicenna Oncology GMBH for the CLR 2000 Series, Orano Med for the CLR 12120 Series, as well as IntoCell Inc. and LegoChemBio. Established in 2002, Cellectar Biosciences maintains its corporate headquarters in Florham Park, New Jersey.
Compare CLRB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CLRB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLRB position with:
🌍 CLRB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CLRB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 78.74% | 75.94% | $7,874 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 66.93% | 64.13% | $6,693 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 62.99% | 60.19% | $6,299 / yr |
| 🇬🇧 UK ISA | 0% | 78.74% | 75.94% | $7,874 / yr |
| 🇬🇧 UK Taxable | 8.75% | 71.85% | 69.05% | $7,185 / yr |
| 🇨🇦 TFSA | 0% | 78.74% | 75.94% | $7,874 / yr |
| 🇨🇦 CA Taxable | 25% | 59.05% | 56.25% | $5,905 / yr |
| 🇦🇺 Super (pension) | 15% | 66.93% | 64.13% | $6,693 / yr |
| 🇦🇺 AU Taxable | 30% | 55.12% | 52.32% | $5,512 / yr |
| 🇩🇪 DE Taxable | 26.375% | 57.97% | 55.17% | $5,797 / yr |
| 🇫🇷 FR Taxable | 30% | 55.12% | 52.32% | $5,512 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CLRB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CLRB Dividend Payment Schedule
CLRB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CLRB vs Healthcare Benchmarks
How CLRB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLRB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CLRB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-08 | 15,000 | $2.69 | $40.4K | ||
| A-Award | 2026-07-07 | 92,000 | $3.14 | $288.9K | ||
| A-Award | 2026-07-07 | 25,000 | $2.70 | $67.5K | ||
| A-Award | 2026-07-07 | 25,000 | $2.70 | $67.5K | ||
| A-Award | 2026-07-07 | 250,000 | $3.14 | $785.0K | ||
| A-Award | 2026-07-07 | 25,000 | $2.70 | $67.5K | ||
| A-Award | 2026-07-07 | 118,000 | $3.14 | $370.5K | ||
| A-Award | 2026-07-07 | 37,500 | $2.70 | $101.3K | ||
| A-Award | 2026-07-07 | 25,000 | $2.70 | $67.5K | ||
| A-Award | 2026-07-08 | 15,000 | $2.68 | $40.2K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLRB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Cellectar Biosciences, Inc. (CLRB) is currently trading at $2.54, trading near its 52-week low. The current dividend yield is 78.74% based on an annual payout of $2.00 per share.
CLRB (Cellectar Biosciences, Inc.) — 78.74% Dividend Yield Analysis
Cellectar Biosciences, Inc. (CLRB) is a healthcare stock currently trading at $2.54 with a dividend yield of 78.74%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (78.74%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CLRB News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.